United States · FDA National Drug Code directory

Losartan Potassium and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68180-217_84f3649d-3ced-4765-ba22-d0fbaeffa820
Product NDC: 68180-217
Form: TABLET
Composition / generic term: Losartan Potassium and Hydrochlorothiazide
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20101006
Source listing expiry: 20271231

Source-listed ingredients

HYDROCHLOROTHIAZIDE — 25 mg/1
LOSARTAN POTASSIUM — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (68180-217-06) · 68180-217-06
90 TABLET in 1 BOTTLE (68180-217-09) · 68180-217-09

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →